OrsoBio

About:

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

Website: https://orsobio.com

Twitter/X: OrsoBio

Top Investors: Eli Lilly, Enavate Sciences, Samsara BioCapital, Woodline Partners, Longitude Capital

Description:

OrsoBio is a clinical-stage biopharmaceutical company that creates therapies for patients suffering from severe metabolic disorders such as diabetes, severe dyslipidemia, lipodystrophies, and others. OrsoBio is committed to restoring energy homeostasis in patients with severe metabolic disorders, in some cases, by targeting pathways relevant to maintaining energy balance. OrsoBio revolutionizes the treatment of these disorders by addressing the underlying cause.